Revvity and Eli Lilly Expand AI Drug Discovery Collaboration via Signals Xynthetica

Revvity, Inc. announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by ma...

January 12, 2026 | Monday | News
Codexis and Axolabs Partner to Evaluate Enzymatic RNA Manufacturing Platform

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of LGC Gr...

January 12, 2026 | Monday | News
Shilpa Medicare’s OERIS™ Clears Phase 3, Showing Superior Convenience, Efficacy and Safety in CINV

Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondans...

January 12, 2026 | Monday | News
Charles River Laboratories Charts A Deliberate Leadership Transition To Power Its Next Phase Of Growth

Charles River Laboratories’ announcement of a planned leadership transition marks one of the most consequential succession moments in the global pr...

January 09, 2026 | Friday | News
Early Prescriber Confidence Is Clear,” Says LENZ Therapeutics CEO Eef Schimmelpennink as VIZZ Launch Exceeds Expectations

Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-...

January 09, 2026 | Friday | Company results
Sharp Sterile Advances Global Growth Strategy With $28M Lee Facility Expansion

Sharp Sterile Manufacturing has  announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will st...

January 09, 2026 | Friday | News
HealthBiome Secures Dual U.S. FDA and Korean MFDS Approvals for Akkermansia Postbiotic with Muscle Health Claim

Akkermansia muciniphila postbiotic receives both U.S. FDA dietary supplement clearance and Korean functional ingredient approval with muscle health ...

January 08, 2026 | Thursday | News
Prokaryotics and Basilea Enter Collaboration to Develop First-in-Class Broad-Spectrum Antifungal

Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infectives,  announced an agree...

January 08, 2026 | Thursday | News
Fagron Completes Acquisition of Purifarma in Brazil

Fagron, the leading global player in pharmaceutical compounding, is pleased to announce the completion of Purifarma in Brazil, an important milestone in ...

January 07, 2026 | Wednesday | News
FUJIFILM Biosciences Name Change Takes Effect As Life Sciences Group Restructuring Moves Into Execution

Rebrand announced in June as part of Fujifilm Life Sciences Group restructuring becomes official FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences...

January 06, 2026 | Tuesday | News
Hoth Therapeutics Files Two U.S. Provisional Patents to Establish Oncology-Focused Dermatology Platform

- Hoth Therapeutics (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies for underserved medical needs,  ...

January 06, 2026 | Tuesday | News
Insilico Medicine and Servier Enter AI-Driven Oncology R&D Collaboration Valued at Up to US$888 Million

Insilico Medicine achieved an R&D collaboration with Servier valued at up to US$888 million, focused on discovering and de...

January 06, 2026 | Tuesday | News
Earendil Labs and Sanofi Forge Strategic Collaboration to Advance AI-Discovered Bispecific Therapies for Autoimmune Diseases

Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, announced a strategic collaboration with ...

January 06, 2026 | Tuesday | News
XORTX Highlights Genetic Drivers of Gout and Kidney Disease, Strengthening Case for Xanthine Oxidase Inhibition

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney dis...

January 05, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close